These PTM alterations may play an important role in the pathophysiology of the disease, as evidenced by the discovery of aberrant phosphorylation patterns in signaling proteins implicated in kidney fibrosis and the association of CKD with the aberrant glycosylation of uromodulin. The gene discussed is UMOD; the disease is chronic kidney disease.